Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥15.99
Day range
¥15.88 - ¥16.22
Year range
¥8.01 - ¥16.51
Market cap
6.49B CNY
Avg Volume
5.16M
P/E ratio
163.29
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 87.49M | 23.58% |
Operating expense | 89.97M | -8.99% |
Net income | -7.07M | 72.79% |
Net profit margin | -8.09 | 77.97% |
Earnings per share | — | — |
EBITDA | -1.24M | 95.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 214.08M | -33.58% |
Total assets | 1.77B | 11.28% |
Total liabilities | 845.66M | 23.19% |
Total equity | 928.37M | — |
Shares outstanding | 406.55M | — |
Price to book | 7.08 | — |
Return on assets | -1.15% | — |
Return on capital | -1.58% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.07M | 72.79% |
Cash from operations | -23.50M | 64.06% |
Cash from investing | -23.42M | 65.21% |
Cash from financing | 14.24M | -77.74% |
Net change in cash | -32.68M | 52.46% |
Free cash flow | -53.68M | 52.79% |
About
Founded
Dec 11, 2009
Website
Employees
470
